• Align Technology, Inc.: Baptista Research upgrades to buy from hold with a price target raised from USD 253 to USD 282.20.
  • Alphabet Inc.: CTBC Securities Investment Service Co LTD downgrades to neutral from buy with a target price reduced from USD 200 to USD 180.
  • Amd (Advanced Micro Devices): Punto Research upgrades to hold from buy with a price target raised from USD 159.56 to USD 170.22.
  • Dt Midstream, Inc.: Stifel downgrades to hold from buy and raises the target price from USD 78 to USD 89.
  • Edwards Lifesciences Corporation: Daiwa Securities downgrades to neutral from outperform with a target price of USD 72.
  • Graphic Packaging Holding Company: Truist Securities downgrades to hold from buy with a price target reduced from USD 32 to USD 30.
  • Lear Corporation: Barclays downgrades to equalweight from overweight with a price target reduced from USD 140 to USD 120.
  • Masco Corporation: RBC Capital downgrades to sector perform from outperform with a target price raised from USD 79 to USD 80.
  • Nvidia Corporation: Punto Research downgrades to sell from hold with a target price of USD 126.70.
  • Qorvo, Inc.: CTBC Securities Investment Service Co LTD downgrades to reduce from neutral with a price target reduced from USD 110 to USD 90. 
  • Selective Insurance Group, Inc.: BMO Capital Markets upgrades to outperform from market perform and raises the target price from USD 95 to USD 105.
  • Allison Transmission Holdings, Inc.: Oppenheimer maintains its outperform rating and raises the target price from USD 90 to USD 115.
  • Biomarin Pharmaceutical Inc.: Leerink Partners maintains its outperform rating and reduces the target price from USD 132 to USD 105.
  • Boyd Gaming Corporation: Raymond James maintains its outperform rating and raises the target price from USD 67 to USD 81.
  • Corning Incorporated: HSBC maintains its hold recommendation with a price target raised from 37 to USD 51. 
  • Crocs, Inc.: BNP Paribas Exane maintains its neutral recommendation with a price target reduced from USD 128 to USD 100. 
  • Doximity, Inc.: Morgan Stanley maintains its underweight recommendation and raises the target price from USD 26 to USD 33.
  • E.l.f. Beauty, Inc.: Jefferies maintains its buy recommendation and reduces the target price from USD 220 to USD 175.
  • Encompass Health Corporation: Deutsche Bank maintains its buy recommendation and raises the target price from USD 95 to USD 118.
  • Exelixis, Inc.: Citigroup maintains its buy recommendation with a price target raised from USD 31 to USD 38. 
  • Leidos Holdings, Inc.: RBC Capital maintains its sector perform recommendation with a price target raised from 145 to USD 180.
  • Monster Beverage Corporation: Evercore ISI maintains its outperform recommendation and reduces the target price from USD 60 to USD 30.
  • Paypal Holdings, Inc.: Punto Research maintains its buy recommendation and raises the target price from USD 76 to USD 93.83.
  • Qorvo, Inc.: BNP Paribas Exane downgrades to neutral from outperform with a price target reduced from USD 117 to USD 80. 
  • Reddit, Inc.: Goldman Sachs maintains its neutral recommendation with a price target raised from 68 to USD 105.
  • Royal Caribbean Group: HSBC maintains its buy recommendation with a price target raised from 185 to USD 242.
  • Tenet Healthcare Corporation: Deutsche Bank maintains its buy recommendation and raises the target price from 160 to USD 200.
  • Tyler Technologies, Inc.: Baptista Research maintains its hold recommendation with a price target raised from 505 to USD 638.60.
  • Admiral Group Plc: HSBC upgrades to buy from hold with a target price of GBP 33.
  • Bridgepoint Group Plc: Citi downgrades to neutral from buy with a price target raised from GBP 3.20 to GBP 3.50.
  • Burberry Group Plc: Bernstein upgrades to outperform from market perform with a price target raised from GBX 680 to GBX 930. 
  • Hunting Plc: Kepler Cheuvreux upgrades to buy from hold with a target price reduced from GBX 450 to GBX 435.
  • Lloyds Banking Group Plc: Morgan Stanley downgrades to equalwt from overwt with a target price reduced from GBX 70 to GBX 65.